VRCA
Verrica Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.30
−1.12%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.99x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 21.14x
- Price / sales
- 3.00x
- Price / cash flow
- -6.82x
Enterprise value
- Enterprise value
- $81.7M
- EV / sales
- 2.69x
- EV / EBITDA
- -3.04x
- EV / EBIT
- -2.90x
- Market cap
- $91.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026